Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The provision of a vaccine to protect against herpes zoster, also known as shingles, to be used in the national immunisation programme.
This notice provides an indication to the market of UKHSA’s intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the herpes zoster, inactivated (shingles) vaccine, in accordance with JCVI advice.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| GlaxoSmithKline UK Limited | 04310159 | ~£0 estimated from lot values | 1 lot Lot 1 | LOBBYIST Hill & Knowlton Limited (4 quarters) Global Counsel Ltd (1 quarter) |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 1 | - | GlaxoSmithKline UK Limited | pending |
Government spending data: This supplier has received £291,004,195 in 110 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care (2021-01-21 to 2026-03-12). View full payment history →